Answering the narrow version, because the broad one does not have a single answer. Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion. Synthesis, testing, and cold-chain shipping have floors. A price well under the floor means something was skipped, and the two things that get skipped are testing and content.

LipidDoc_ATL said:

Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion.

Right, and one flattering data point from a group buy is not consistency. Consistency means separate batches, separately commissioned, over months.

SkepticalSean said:

Six orders from the same supplier over eight months, every one independently tested, and the consistency is the part worth reporting rather than any…

This matches mine closely enough to be worth saying so. The pattern that distinguishes a bad batch from an exit is behaviour rather than product. A bad batch comes with communication, a reshipment offer and a batch number. An exit comes with slower replies, pressure toward less reversible payment methods, sudden discounting, and the same reassurance repeated without any new information. The product tells you less than the correspondence does.

Adding the clinical framing, because it changes how the question reads.

Shipping damage protocol for vendor vetting orders: if your package arrives with visible damage, temperature excursion, or broken vials:

• Photograph EVERYTHING before discarding packaging
• Note the temperature of the cold pack (liquid = possibly too warm)
• Contact the vendor within 24 hours with photos
• Request a replacement shipment or refund
• Do NOT use potentially compromised medication

Reputable vendors will replace damaged shipments without argument. If they push back, that's a red flag about the vendor.